Identification of Serum and Urine Biomarkers of Type 1 Diabetes

Study Overview

The purpose of this study is to identify biomarkers (small molecules in the blood) that can predict those people at risk of developing Type 1 diabetes.

Study Description

The purpose of this study is to develop and validate biomarkers that predict T1D disease risk and document disease progression based on blood or urine indicators of beta cell stress and death in emerging and establish T1D.

Additional Information:

Participants will be compensated for their participation.

Research Study Identifier: TX4884

ClinicalTrials.gov Identifier: NCT1411938757

Principal Investigator: Carmella Evans-Molina

Currently Recruiting

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

Last Name

First name is mandatory

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Last Updated: Jan 28, 2019

Recruitment Status: Open